Streams

Massachusetts Seeks to Revoke License of Company Linked to Meningitis Outbreak

Tuesday, October 23, 2012

Massachusetts Governor Deval Patrick said the state has moved to revoke the licenses of the New England Compounding Center and three pharmacists there. He also has ordered the state pharmacy board that oversees similar companies to conduct surprise inspections and take other steps to tighten oversight.

The pharmacy is linked to a deadly outbreak of meningitis that has affected people in 17 states and has lead to 23 deaths. Seventeen cases in N.J. and one case in N.Y. have been linked to the tainted steroids, according to the Centers for Disease Control.

State officials said Tuesday they found unclean conditions including visible black specks of fungus in steroids and a leaking boiler near what was supposed to be a clean room at NECC.

A preliminary investigation found that the NECC shipped orders from the lots of steroid shots suspected in the meningitis outbreak before its own tests came back confirming the lots were sterile, according to state officials. In some cases, they said, drugs went out up to 11 days before test results came back.

Officials also said the company, in Framingham, just west of Boston, operated as a drug manufacturer by producing drugs for broader use, rather than filling out specific prescriptions for specific doctors, which is all its license allowed.

"Over the years and for a variety of reasons, some pharmacists have transformed from your neighborhood drugstore into large-scale manufacturers that sell products across state lines," Patrick said.

In a letter sent Monday to a lawyer for NECC, the U.S. House Committee on Energy and Commerce sought nearly 10 years of documents about safety and quality issues at the company. It indicated that as far back as 2002 and 2003 officials from the Food and Drug Administration and the state conducted joint probes of the company after receiving a report about a steroid shot. Those probes preceded a 2004 joint investigation of the center by the FDA and the Massachusetts Board of Registration in Pharmacy.

In January 2006, based on several complaints, the company signed with state regulators a consent agreement in which it agreed to a full inspection of its drug compounding practices by investigators.

The company's encounters with regulators have been reported since the outbreak began, but state pharmacy board documents released Monday offer a new level of detail. They show the inspection by Illinois-based Pharmaceutical Systems Inc. found "significant gaps" in procedures and a lack of required documentation at the NECC facility.

NECC spokesman Andrew Paven said he hadn't seen the committee's letter but the company continues to cooperate with the ongoing investigation.

"NECC worked cooperatively with the Massachusetts Board of Registration in Pharmacy to resolve to the Board's satisfaction any issues brought to the company's attention," he said by email.

Tags:

More in:

News, weather, Radiolab, Brian Lehrer and more.
Get the best of WNYC in your inbox, every morning.

Comments [1]

Why not just let the free market system sort this out? A few innocent deaths in the short term is the price of free markets. In the long run, the market will fix it. Ask Mitt. He went to HBS so he knows.

Oct. 24 2012 09:19 AM

Leave a Comment

Register for your own account so you can vote on comments, save your favorites, and more. Learn more.
Please stay on topic, be civil, and be brief.
Email addresses are never displayed, but they are required to confirm your comments. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting. By leaving a comment, you agree to New York Public Radio's Privacy Policy and Terms Of Use.

Sponsored

Latest Newscast

 

 

Support

WNYC is supported by the Charles H. Revson Foundation: Because a great city needs an informed and engaged public

Feeds

Supported by